Time is a critical factor in any cancer diagnosis. Data-driven insights, advances in diagnostics and improved access to care are reducing delays between diagnosis and treatment, improving patient...
In this article, Dr Daniel Tan introduces Tumour Treating Fields, a promising therapy for patients with glioblastoma multiforme. Glioblastoma multiforme or GBM is a feared, lethal and aggressive...
Researchers from Duke-NUS Medical School in Singapore and Columbia University in the US have solved how Wnt proteins, which play a fundamental role in cell proliferation and differentiation, hitch a...
The global COVID-19 pandemic has triggered dramatic changes in working practices of hospitals, especially strategies for treating and caring for high-risk patients. With every healthcare institution...
Researchers from the National University of Singapore (NUS) have developed a new way to treat sewage that is much simpler, cheaper and greener than existing methods through a new strain of bacterium...
Axios International announced the development of the Patient Financial Eligibility Tool (PFET) as a sustainable approach to alleviate the costs borne by patients through the determination of how much...
Researchers from Karolinska Institutet in Sweden and MD Anderson Cancer Centre in Texas discover possibility of a new treatment strategy of childhood sarcoma using common prescribed anti-depressant...
Singapore-based clinical-stage biotechnology company, Tychan announces results for Phase 1 Trial for TY014, a novel monoclonal antibody candidate treatment for yellow fever. Results of Phase 1 trial...
Researchers from Nanjing University and two other groups from Wuhan Institute of Virology and the Second Hospital of Nanjing discover miRNA in honeysuckle decoction (HD) can directly target...
The Japan Ministry of Health, Labour and Welfare (MHLW) approves the use of XTANDI® (enzalutamide) by Astellas Pharma Inc., for the treatment of prostate cancer with distant metastasis. XTANDI®...
Clinicians in Hong Kong leverage on cutting-edge wearable and artificial intelligence technology developed by Biofourmis to accelerate disease surveillance and interventions. Digital therapeutics...
Research team from the Queen Mary University of London reports on the effectiveness of anastrozole as a prophylactic therapy in postmenopausal women. Breast cancer is the most common cancer in women...
